The risk of cutaneous squamous cell carcinoma (SCC) is increased in patients with immunosuppression and associated with beta human papilloma virus (β-HPV). Strickley, Messerschmidt et al. now show that β-HPV infection itself is not causal in SCC development in the context of immunosuppression, but instead it is the loss of β-HPV-mediated T cell immunity that promotes SCC in this context.
β-HPV infection has been hypothesized to facilitate the initiation of carcinogen-driven skin cancer. The authors used back-skin infection of mouse papillomavirus type 1 (MmuPV1) in mice to model carcinogen-driven SCC. C57BL/6J mice infected with MmuPV1 or sham infected were exposed to a chemical carcinogen protocol 2 months after infection, for 30 weeks. MmuPV1-infected mice developed skin tumours, although onset was delayed and the tumour burden was lower than in sham-infected mice. When immunodeficient Cd4−/−Cd8−/− mice were infected with MmuPV1, they developed confluent warts, in contrast to immunocompetent MmuPV1-infected control mice. However, when memory T cells from MmuPV1-infected control mice were transferred to Cd4−/−Cd8−/− mice, MmuPV1 infection led to fewer skin warts than in those Cd4−/−Cd8−/− mice that did not receive these T cells. Similarly, the adoptive transfer of memory T cells from MmuPV1-immune mice led to regression of persistent warts in MmuPV1-colonized FVB mice. These mice were also protected from chemical carcinogenesis, suggesting that T cells from MmuPV1-immune mice confer antiviral adaptive immunity that can protect from carcinogenesis.
Moving on to explore ultraviolet (UV) radiation-induced SCC, the authors used the MmuPV1–back-skin infection system in SKH-1 hairless mice. MmuPV1- or sham-infected mice underwent UVB radiation three times a week for 25 weeks, which led to tumour development in both conditions, although MmuPV1-infected mice had fewer tumours and a lower tumour burden than sham-infected mice. Of note, when UVB treatment cycles were completed, the skin of MmuPV1-colonized mice as well as their skin tumours had an increased number of CD8+ T cells compared with sham-infected control mice. When SKH-1 mice underwent antibody-mediated CD8+ T cell depletion after infection with MmuPV1 or sham infection, control MmuPV1-colonized mice developed fewer UVB-induced tumours than the CD8+ T cell-depleted MmuPV1-colonized mice, and fewer tumours than sham(VLP)-infected mice in either treatment group.
Moving on to patients, the authors analysed β-HPV infection in SCC lesions from patients with or without immunosuppression, using RNA in situ hybridization to detect E6 transcripts of 25 types of β-HPV. SCC lesions from patients with immunosuppression had higher levels of β-HPV RNA expression than SCC lesions from immunocompetent patients. Also, β-HPV RNA expression was reduced in cancer cells compared with adjacent normal skin cells in both groups. These results were reflected in a higher viral load in SCC lesions in patients with immunosuppression compared with immunocompetent patients, and also correlated with fewer tumour- and skin-infiltrating CD8+ T cells in patients with immunosuppression. In line with antiviral adaptive immunity in immunocompetent patients, β-HPV E7 peptides were able to activate CD8+ T cells isolated from the normal facial skin of these patients. Returning to their animal model, the authors performed RNA sequencing of skin warts, MmuPV1-infected UVB-treated skin and tumours, and sham-infected tumours of SKH-1 mice. Among the genes that were upregulated in MmuPV1-induced warts and UVB-induced tumours from MmuPV1-infected compared with sham-infected mice, immune-related genes including damage-associated molecular pattern (DAMP) genes were detected.
control MmuPV1-colonized mice developed fewer UVB-induced tumours than the CD8+ T cell-depleted MmuPV1-colonized mice
This study highlights the role of commensal HPVs in priming adaptive immunity in immunocompetent hosts and presents an opportunity for developing antiviral T cell-based vaccines to prevent skin carcinogenesis.
References
Original article
Strickley, J. D. et al. Immunity to commensal papillomaviruses protects against skin cancer. Nature https://doi.org/10.1038/s41586-019-1719-9 (2019)
Related article
Elinav, E. et al. The cancer microbiome. Nat. Rev. Cancer 19, 371–376 (2019)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harjes, U. Benevolent viruses in skin cancer. Nat Rev Cancer 20, 2 (2020). https://doi.org/10.1038/s41568-019-0229-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-019-0229-2